Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

dopharma research -

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aurobindo pharma limited - simvastatin - filmsko obložena tableta - simvastatin 40 mg / 1 tableta - simvastatin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aurobindo pharma limited - simvastatin - filmsko obložena tableta - simvastatin 20 mg / 1 tableta - simvastatin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aurobindo pharma limited - simvastatin - filmsko obložena tableta - simvastatin 40 mg / 1 tableta - simvastatin

Evropska unija - slovenščina - EMA (European Medicines Agency)

dopharma research b.v. - meloksikam - oxicams - pigs; calves - cattlefor uporabo v akutne okužbe dihal in z ustreznimi antibiotiki terapije za zmanjšanje kliničnih znakov goveda. za uporabo v driske v kombinaciji z oralno rehidracijo terapije za zmanjšanje kliničnih znakov, v teleta v enem tednu starosti in mladim, ki niso doječe goveda. za dodatno zdravljenje pri zdravljenju akutnega mastitisa, v kombinaciji z antibiotično terapijo. pigsfor uporabo v noninfectious gibalne motnje za zmanjšanje simptomov lameness in vnetje. za lajšanje pooperativne bolečine, povezane z manjšimi operacijami mehkega tkiva, kot je kastracija. za dodatno zdravljenje pri zdravljenju puerperalne septikemije in toksemije (sindroma mastitis-metritis-agalactia) z ustrezno antibiotično terapijo. horsesfor uporabo v lajšanje vnetja in lajšanje bolečine v akutni in kronični mišično-skeletne motnje. za lajšanje bolečin, povezanih z kopitarjem kopitarjev.

Evropska unija - slovenščina - EMA (European Medicines Agency)

mabxience research sl - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastična sredstva - alymsys in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. alymsys in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. alymsys in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with alymsys in combination with capecitabine. alymsys, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer other than predominantly squamous cell histology. alymsys, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non squamous non small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations. alymsys in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. alymsys, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer. alymsys, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - hidroklorotiazid; ramipril - tableta - hidroklorotiazid 25 mg / 1 tableta  ramipril5 mg / 1 tableta; ramipril 5 mg / 1 tableta - ramipril in diuretiki

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - hidroklorotiazid; ramipril - tableta - hidroklorotiazid 12,5 mg / 1 tableta  ramipril2,5 mg / 1 tableta; ramipril 2,5 mg / 1 tableta - ramipril in diuretiki

Evropska unija - slovenščina - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - adalimumab - spondylitis, ankylosing; arthritis, juvenile rheumatoid; uveitis; colitis, ulcerative; psoriasis; arthritis, psoriatic; crohn disease; arthritis, rheumatoid - imunosupresivi - prosimo, glejte dokument o izdelku.

Evropska unija - slovenščina - EMA (European Medicines Agency)

zoetis belgium sa - dibotermin alfa - morfogenetski proteini kosti - psi - osteoinduktivno sredstvo za uporabo pri zdravljenju zlomov z dolgimi kostmi kot dodatka k standardni kirurški posegi z uporabo zmanjšane odpovedi zlomov pri psih.